Efficacy and Tolerance of Glatiramer Acid (Copaxone) on Long-Term Use: 10 Years of Experience at the Moscow City Multiple Sclerosis Center

Overview of attention for article published in Neuroscience and Behavioral Physiology, June 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#16 of 185)
High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 9 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

while drug makers battle in court over popular ms treatment implications for patients remain unclear

HCP Live, 29 Aug 2016

The US Patent and Trade Office ruled last week to invalidate the patents held by Teva on a novel multiple sclerosis (MS…